DENIS HUANG

Allopathic & Osteopathic Physicians|Ophthalmology|Retina Specialist BLUE ASH, OH NPI 1699390773

General Payments — all program years on this page

$1,448.71

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 31
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $697.32 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $697.3220

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $273.576
2023 $477.825
2024 $697.3220

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089507810 EyePoint Pharmaceuticals US, Inc. $61.80 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092829101 Alimera Sciences, Inc. $25.26 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092830899 Alimera Sciences, Inc. $24.79 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092832624 Alimera Sciences, Inc. $66.06 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092837641 Alimera Sciences, Inc. $24.64 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103947622 ABBVIE INC. $33.88 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110705614 Alcon Vision LLC $143.62 06/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114072599 Regeneron Healthcare Solutions, Inc. $35.40 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114072601 Regeneron Healthcare Solutions, Inc. $0.87 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114072603 Regeneron Healthcare Solutions, Inc. $34.59 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114072605 Regeneron Healthcare Solutions, Inc. $3.18 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114072607 Regeneron Healthcare Solutions, Inc. $0.84 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114072609 Regeneron Healthcare Solutions, Inc. $26.73 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114072611 Regeneron Healthcare Solutions, Inc. $35.08 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133000722 Genentech USA, Inc. $17.71 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133000726 Genentech USA, Inc. $19.50 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154019950 Apellis Pharmaceuticals, Inc. $30.74 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154019952 Apellis Pharmaceuticals, Inc. $29.74 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154791970 Dutch Ophthalmic, USA $21.81 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154792190 Dutch Ophthalmic, USA $61.08 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.